ABCG2 and breast cancer: Dong et al. [46] found that bELE decreases the stem cell population (CD44+CD24−/low) and sphere formation ability of the breast cancer cell line MCF‐7/ADM and reduces the drug‐resistant protein breast cancer resistance protein and P‐glycoprotein.